×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Serum Institute allowed to recruit 7-11-year-olds in COVID vaccine trial

  649 Views

Reuters    29 September 2021

The drug regulator in India has allowed Serum Institute to recruit children aged between 7 and 11 years for its COVID-19 vaccine trial.

A subject expert panel of the Central Drugs Standard Control Organization stated that the committee recommended to allow the enrolment of children 7 to 11 years of age as per the protocol, following thorough deliberation.

Serum Institute is already carrying out a study of its COVID-19 vaccine, which is a domestically produced version of Novavax′s vaccine, in 12-17-year-olds, and has submitted safety data for an initial 100 participants.

Only Zydus Cadila′s DNA COVID-19 vaccine has been given emergency use approval in the country thus far for use in adults and children aged 12 years and over.

Source: ET Healthworld

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.